OJEMDA (tovorafenib), FDA Approved for Pediatric Low-Grade Glioma, Available at Biologics by McKesson
Biologics by McKesson joined a limited network as a specialty pharmacy provider for OJEMDA, an oral RAF inhibitor for pediatric low-grade glioma.
Tag: rare and orphan